ADCT β€” ADC THERAPEUTICS SA

Ownership history in Diversified Trust Co  Β·  3 quarters on record

This page tracks every 13F SEC filing in which Diversified Trust Co reported a position in ADC THERAPEUTICS SA (ADCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

Diversified Trust Co Γ— ADCT AI Analytics

πŸ“ˆ Diversified Trust Co outperformed the S&P 500 by +240.9% annually on this ADCT position. Average cost basis: $1.41. Maximum drawdown during holding period: –0.0%.

πŸ“ˆ Position Alpha vs SPY
+240.9%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 240.9% per year on this position.
2 quarters analyzed

πŸ’° Entry Quality
$1.41
+183.7% vs current ($4.00)

Best entry: $1.41 (2025 Q1)  Β·  Worst: $1.41 (2025 Q1)

πŸ›‘οΈ Drawdown Resilience
–0.0%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

1 add Β· 0 trims. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ADCT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 14,115 β€” 0% 0.00% $56K $4.00
2025 Q2 UNCHANGED 14,115 β€” 0% 0.00% $38K $2.68
2025 Q1 INITIATED 14,115 β€” β€” 0.00% $20K $1.41
← Back to Diversified Trust Co Holdings